Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 6.3 | 7.6 | 3.4 | 5.1 | 1.2 |
| Revenue growth | -16.5% | 123.6% | -33.5% | 333.7% | |
| Cost of goods sold | -0.1 | -0.7 | -0.4 | -0.6 | -0.2 |
| Gross profit | 6.5 | 8.2 | 3.8 | 5.7 | 1.4 |
| Gross margin | 102.3% | 108.6% | 111.3% | 112.0% | 117.6% |
| Research and development | 30.2 | 22.0 | 9.6 | 14.4 | 8.7 |
| General and administrative | 8.3 | 7.5 | 2.3 | 7.0 | 3.1 |
| EBIT | -32.0 | -21.3 | -8.2 | -15.7 | -10.4 |
| EBIT margin | -507.5% | -282.2% | -241.8% | -308.7% | -886.4% |
| Pre-tax income | -32.3 | -20.2 | -0.4 | -26.1 | -14.3 |
| Income taxes | 0.1 | 0.0 | 0.2 | 0.0 | 0.0 |
| Tax rate | | 0.0% | | | |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|